3Zalel Y, Shulman A, Lidor A, et al. The local progestational efffect of the levonorgestrel-releasing intrauterine system: a sonographic and Doppler flow study. Hum Reprod, 2002, 17(11):2878-2880.
4Guillebaud .I. The levnorgestrel intrauterine systemL: a clinical perspective from the UK. Ann N Y Acad Sci, 2003, 997(2): 185-193.
5Backman T, Huhtala S, Luoto R, et al. Advance information improves improves user satisfaction with the levonorgestrel intrauterine system.Obstet Gynecol, 2002, 99(4): 608-613.
6French R, Cowan F, Mansour D, et al. Hormonally impregnated intrauterine systems(IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev, 2001,(2):CD001776.
7Backman T, Rauramo I, Huhtala S, et al. Pregancy during the use of levonorgestrel intrauterine system. Am J Obstet Gynecol, 2004, 190(1):50-54.
8Roy SN, Bhattacharya S. Benefits and risks of pharmacological agents used for the treatment of menorrhagia. Drug Saf, 2004, 27(2):75-90.
9Xiao BL, Wu SC, Chong J, et al. Therapeutic effects of the lenonorgestrelrelesing intrauterina system in the treatment of idiopathic menorrhagia. Fertil Steril, 2003, 79(4):963-969.
10Barrington JW, Arunkalivanan AS, Avdek-Fattah M. Compariso between the levonorgestrel intrauterine system (LNG-IUS)and thermal balloon ablation in the treatment of menorrhagia. Eur J Obstet Gynecol Reprod Biol, 2003, 108(1):72-74.
5Bragheto A M, Caserta N, Bahamondes L, et al. Effectiveness of the levonorgestrel-releasing intrauterine system in the the treat- ment of adenomyosis diagnosed and monitored by magnetic reso- nance imaging[J]. Contraception, 2007, 76 (3) : 195-199.
7Sheng J, Zhang W Y, Zhang J P, et al. The LNG-IUS study on adenomyosis: A 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrheal associated with adenomyosis[J]. Con- traception, 2009, 79(3) : 189-193.
